Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DAPAGLIFLOZIN PROPANEDIOL Cause Nausea? 460 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 460 reports of Nausea have been filed in association with DAPAGLIFLOZIN PROPANEDIOL (FARXIGA). This represents 2.7% of all adverse event reports for DAPAGLIFLOZIN PROPANEDIOL.

460
Reports of Nausea with DAPAGLIFLOZIN PROPANEDIOL
2.7%
of all DAPAGLIFLOZIN PROPANEDIOL reports
9
Deaths
98
Hospitalizations

How Dangerous Is Nausea From DAPAGLIFLOZIN PROPANEDIOL?

Of the 460 reports, 9 (2.0%) resulted in death, 98 (21.3%) required hospitalization, and 29 (6.3%) were considered life-threatening.

Is Nausea Listed in the Official Label?

Yes, Nausea is listed as a known adverse reaction in the official FDA drug label for DAPAGLIFLOZIN PROPANEDIOL.

What Other Side Effects Does DAPAGLIFLOZIN PROPANEDIOL Cause?

Death (3,443) Fungal infection (1,204) Blood glucose increased (778) Weight decreased (777) Urinary tract infection (583) Dizziness (582) Diabetic ketoacidosis (547) Fatigue (442) Pollakiuria (388) Cerebrovascular accident (352)

What Other Drugs Cause Nausea?

APREMILAST (21,352) ADALIMUMAB (19,299) METHOTREXATE (18,715) ETANERCEPT (12,174) TREPROSTINIL (10,320) RITUXIMAB (10,250) SEMAGLUTIDE (10,036) TIRZEPATIDE (10,018) LENALIDOMIDE (9,206) DULAGLUTIDE (9,137)

Which DAPAGLIFLOZIN PROPANEDIOL Alternatives Have Lower Nausea Risk?

DAPAGLIFLOZIN PROPANEDIOL vs DAPAGLIFLOZIN PROPANEDIOL\METFORMIN DAPAGLIFLOZIN PROPANEDIOL vs DAPRODUSTAT DAPAGLIFLOZIN PROPANEDIOL vs DAPSONE DAPAGLIFLOZIN PROPANEDIOL vs DAPTOMYCIN DAPAGLIFLOZIN PROPANEDIOL vs DARATUMUMAB

Related Pages

DAPAGLIFLOZIN PROPANEDIOL Full Profile All Nausea Reports All Drugs Causing Nausea DAPAGLIFLOZIN PROPANEDIOL Demographics